Table 2 Overview of patient cohort.
Characteristics | Deterioration | No deterioration |
---|---|---|
Patient, n | 6104 | 30,902 |
Age (years), mean (SD) | 66.0 (18.4) | 63.1 (18.0) |
Sex (females), n (%) | 2539 (41.5) | 17792 (57.5) |
Diabetes w/o complications, n (%) | 1510 (24.7) | 5582 (18.0) |
Diabetes w/ complications, n (%) | 114 (1.8) | 401 (1.2) |
Hypertension, n (%) | 2721 (44.5) | 11,748 (38.0) |
Vaccination n (%) | 2388 (39.1) | 16,776 (54.2) |
Time since last vacination (months), mean (SD) | − 0.67 (6.2) | − 0.94 (7.3) |
Obesity, n (%) | 1003 (16.4) | 5370 (17.3) |
Vital signs feature sets | ||
SpO2 (%), mean (SD) | 95.2 (4.5) | 96.2 (2.7) |
HR (Beats per minute), mean (SD) | 93.98 (27.1) | 82.9 (18.57) |
Temperature (\(^\circ\) F), mean (SD) | 98.37 (1.6) | 98.2 (1.4) |